Top 5 Long Term Stocks For 2014

KeyBanc announced on Tuesday that it has raised its rating on apparel retailer Chico’s FAS, Inc. (CHS) as analysts now see greater long term opportunities for the company.

The firm has upgraded CHS from “Hold” to “Buy,” and has given the company a $21 price target. This price target suggests a 22% upside from the stock’s current price of $16.48.

An analyst from the firm commented: “While the near-term retail env�� remains soft, we believe fundamentals are not so concerning that investors should risk overlooking CHS�� potential over the coming yrs.”

Top 5 Services Stocks To Own For 2015: Beazer Homes USA Inc. (BZH)

Beazer Homes USA, Inc. designs, builds, and sells single-family and multi-family homes. The company offers homes for entry-level, move-up, or retirement-oriented buyers. It also engages in rental of previously owned homes that are purchased and improved by the company. The company sells its homes through commissioned new home sales counselors and independent brokers. It operates in 16 states, including Arizona, California, Delaware, Florida, Georgia, Indiana, Maryland, Nevada, New Jersey, New York, North Carolina, Pennsylvania, South Carolina, Tennessee, Texas, and Virginia. Beazer Homes USA, Inc. was founded in 1985 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By Jacob Roche]

  Sherwin-Williams, along with some other home-improvement stocks, benefits from being part of that rare breed of stocks that do well when times are good, and still do well when times are bad. If the housing market is good, new homes get built en masse, and those homes need to be painted and floored. Hence, with U.S. housing starts up nearly 90% over the past couple of years, homebuilders KB Homes (NYSE: KBH  ) and Beazer Homes (NYSE: BZH  ) have seen revenues finally starting to recover, and companies such as Sherwin-Williams and Lumber Liquidators (NYSE: LL  ) are being pulled along for the ride.

• [By Erika Janowicz]

  Compass Point analyst Wilkes Graham updated his housing forecast:

  Graham increased assumed ROI's to 9% on average from 7%. Reduced targeted sector price/ book from $190% to 170%. Expects 20-30% growth in starts and new home sales in 2012 and 2013 to stabilize in 2014 and on at approximately 10%. For covered builders, the analyst lowered estimates by 8% and lowered price targets by 10%. Compass Point expects 10% annual growth in single family starts and new home sales and 2-5% pricing growth. Downgraded DR Horton Inc. (NYSE: DHI) from Buy to Neutral and KB Home (NYSE: KBH) from Neutral to Sell. DR Horton's and KB Home's PT was lowered from $23.50 to $20.00 and from $17.50 to $14.00, respectively. Graham reiterated a Buy rating on Ryland Group Inc. (NYSE: RYL) and Standard Pacific Corp. (NYSE: SPF). The analyst raised the PT on Ryland from $50.00 to $50.50 and lowered the PT on Standard Pacific from $10.00 to $9.50. Compass Point reiterated a Neutral rating on Beazer Homes USA Inc. (NYSE: BZH), Hovnanian Enterprises Inc. (NYSE: HOV), Lennar Corp. (NYSE: LEN), PulteGroup, Inc. (NYSE: PHM), and Toll Brothers Inc. (NYSE: TOL). The price target for Beazer and Hovnanian was raised from $15.50 to $24.00 and $5.00 to $5.75, respectively. Graham lowered the PT for Lennar, Pulte, and Toll to $34.50, $17.00, and $31.00.

  This Week's Data

• [By Sean Williams]

  The other factor that'll weigh on Trulia's success or failure is whether or not the homebuilding market is cooperating. Luckily for Trulia, we're seeing continued signs of success across the board with the National Association of Home Builders Housing Market Index coming in at a seven-year high yesterday. KB Home (NYSE: KBH  ) , for instance, which focuses on middle-and-upper income first-time and trade-up buyers, saw revenue increase 59% in the first-quarter from the year-ago period as its average selling price vaulted higher by 24%. Even struggling homebuilder Beazer Homes (NYSE: BZH  ) , which tends to market toward lower- to middle-income first-time buyers and retired persons, saw its revenue leap 51% as average selling prices added nearly 13% in the second quarter. The point is that low inventory levels are leading to higher home prices and renewed interest in owning a home.

Top 5 Long Term Stocks For 2014: National Australia Bank Ltd (NAUBF)

National Australia Bank Limited is a financial services organization providing products, advice and services through its major Australian franchise and businesses. The Company�� segment includes Business Banking, Personal Banking, Wholesale Banking, UK Banking and NZ Banking, MLC and NAB, Great Western Bank (GWB), the Corporate Functions and Other segment. MLC is the wealth management division of the National Australia Bank (NAB). In January 2014, Sandfire Resources NL announced that National Australia Bank Limited and its associated entities have ceased to be the substantial holder of the Company. In January 2014, Commonwealth Property Office Fund announced that National Australia Bank Ltd and its associated entities have ceased to be a substantial shareholder in Commonwealth Property Office Fund. In February 2014, Fairfax Media Ltd announced that National Australia Bank Ltd and its associated entities ceased holding interest in the capital of the Company. Advisors' Opinion:

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- Australia shares nudged lower early Friday, with the S&P/ASX 200 (AU:XJO) down 0.2% to erase the previous session's 0.2% gain, dragged by losses for European and U.S. equities on the back of a Portuguese financial crisis. Financials fell (Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) and National Australia Bank Ltd. (AU:NAB) (NAUBF) each down 0.3%, Commonwealth Bank of Australia (AU:CBA) (CBAUF) down 0.4%, and Macquarie Group Ltd. (AU:MQG) (MCQEF) down 0.7%), and the top miners fared especially poorly (Rio Tinto Ltd. (AU:RIO) (RIO) down 1.2%, Oz Minerals Ltd. (AU:OZL) (OZMLF) down 1.1%, though BHP Billiton Ltd. (AU:BHP) (BHP) off just 0.1%). And while Atlas Iron Ltd. (AU:AGO) beat its production guidance, and Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) missed its production guidance, both saw losses, with Atlas stock off 2.9% and Fortescue trading 1.6% lower. Among the gainers, Scentre Group

Top 5 Long Term Stocks For 2014: Lexicon Pharmaceuticals Inc.(LXRX)

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of various human diseases. The company utilizes gene knockout technologies and an integrated platform of medical technologies to systematically study the physiological and behavioral functions of approximately 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. Its portfolio of orally-delivered small molecule compounds that have completed or are presently conducting phase 2 clinical trails includes LX4211 for the treatment of type 2 diabetes; LX1031 for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX1032 for the treatment of the symptoms associated with carcinoid syndrome; and LX2931 for the treatment of rheumatoid arthritis and other autoimmune diseases. The company also develops LX1033, an orally-delivered small molecule compound that is in phase 1 clinical trails for the treatment of irritable bowel syndrome and other gastrointestinal disorders. In addition, it develops three orally-delivered small molecule compounds in preclinical development stage that include LX7101 for treatment of glaucoma; LX5061 for the treatment of osteoporosis; and LX2311 for the treatment of autoimmune diseases. Further, the company has small molecule compounds from various additional drug discovery programs in various stages of preclinical research. It has drug discovery and development collaborations with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. The company also has a series of agreements with Symphony Icon, Inc. for the financing of clinical development programs; and an alliance with Nuevolution A/S to access Nuevolution?s Chemetics chemistry technology. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.

Advisors' Opinion:

• [By Garrett Cook]

  Lexicon Pharmaceuticals (NASDAQ: LXRX) shares were also up, gaining 3.18 percent to $1.62. Lexicon and JDRF have collaborated for Phase 2 clinical trial of LX4211 in Type 1 Diabetes.

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Tuesday’s session are Diamond Foods Inc.(DMND), Edgen Group Inc.(EDG) and Lexicon Pharmaceuticals Inc.(LXRX)

Top 5 Long Term Stocks For 2014: Graham Corp (GHM)

Graham Corporation (Graham), incorporated on March 7, 1983, designs, manufactures and sells critical equipment for the energy industry which includes the oil refining, petrochemical, as well as cogeneration, nuclear and alternative power markets. It design and manufacture custom-engineered ejectors, pumps, surface condensers and vacuum systems as well as supplies and components for inside the reactor vessel and outside the containment vessel of nuclear power facilities. Its equipment is also used in nuclear propulsion power systems for the defense industry and can be found in other diverse applications such as metal refining, pulp and paper processing, water heating, refrigeration, desalination, food processing, pharmaceutical, heating, ventilating and air conditioning. The Company�� two wholly owned subsidiaries include Graham Vacuum and Heat transfers Technology (Suzhou) Co., Ltd.

The Company's products are used in a range of industrial process applications, including Chemical and Petrochemical Processing, such as ethylene, methanol and nitrogen producing plants, plastics, resins and fibers plants and petrochemical intermediate plants, and Power Generation /Alternative Energy, such as propulsion systems for nuclear-powered aircraft carriers and other nuclear- powered vessels, air conditioning and water heating systems and liquefied natural gas production facilities. The Company's principal customers are in the chemical, petrochemical, petroleum refining and power generating industries, and are users of the Company's products in their manufacturing, refining and power generation processes, large engineering companies that build installations for companies in such industries, and/or the original equipment manufacturers, who combine its products with their equipment prior to its sale to end users.

The Company competes with Gardner Denver, Inc., GEA Wiegand GmbH, Edwards, Ltd, Korting Hannover AG, Croll Reynolds Company, Inc, Schutte Koerting, Gardner Denver, Inc, DongHwa En! tec Co., Ltd, Hangzhou Turbine Equipment Co., Chem Process Systems, Mazda (India), Oeltechnik GmbH, KEMCO, Holtec, Thermal Engineering International, SPX Heat Transfer, Chem Process Systems, Mazda (India)., Ambassador, Alfa Laval AB, APV, Xylem, Dubose, Consolidated, Tioga, Nova, Joseph Oats and Energy & Process.

Advisors' Opinion:

• [By Rick Munarriz]

  Friday
  The market is typically quiet on Friday, but don't tell that to Graham (NYSEMKT: GHM  ) . The maker of custom-engineered ejectors, pumps, condensers, vacuum systems, and heat exchangers reports on Friday morning. Analysts see profitability almost quadrupling to $0.31 a share, and revenue soaring 48%.